On the recordSeptember 4, 2018
I am hoping, not just the PBMs, but the entire system of drug pricing is something we should be having hearings on.
Source
congress.govEditor's note · Context
DeGette emphasizes the need for hearings on drug pricing and PBMs due to public concern.
Share
More from Diana DeGette
Mar 28, 2023
It is a little embarrassing for someone like me, who is trying to tell colleagues around the world that we need to have robust oversight, that the U.S. Congress is actually having an oversight hearing that is so vague that you can't…
Jun 9, 2026
Trump is coming after our elections, and we cannot let him. He has taken a sledgehammer to voting rights, not just to entrench his own power but to do it at the expense of voters in Black and brown communities.
Jun 20, 2023
we all agree on this committee in a bipartisan way that lithium and cobalt are going to be essential for the clean energy transition.
Jun 23, 2026
New allies should know that voters who have not returned their ballots need to see contrast communications in the mailboxes — followed by TV and digital targeted to likely voters 40+.
Other voices in this conversation
